US 11253604
Conjugate of methotrexate and peptide
granted A61KA61K31/519A61K47/64
Quick answer
US patent 11253604 (Conjugate of methotrexate and peptide) held by CAREGEN CO., LTD. expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAREGEN CO., LTD.
- Grant date
- Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/519, A61K47/64, A61K9/0019, A61K9/08